Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Cotter

Showing results (101-110 of 290) with videos related to

Pageof 29
Sort By:
ESC Heart Failure|November 28, 2020
N-terminal pro BNP and galectin-3 are prognostic biomarkers of acute heart failure in sub-Saharan Africa: lessons from the BAHEF trialMahmoud U Sani, Albertino Damasceno, Beth A Davison, et al.
Cardiology|September 18, 2007
Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension--a multi-center randomized studyEdo Kaluski, Gad Cotter, Marina Leitman, et al.
Journal of Cardiac Failure|February 14, 2025
Acute Heart Failure: Transitioning From Symptom-Based Care to RemissionGad Cotter, Beth A Davison, Douglas L Mann, et al.
Journal of Cardiac Failure|February 4, 2010
Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal functionBeth Davison Weatherley, Gad Cotter, Howard C Dittrich, et al.
Scientific Reports|August 12, 2025
Reducing blood pressure variability-results from a single-arm proof of concept prospective trialEyal Shemesh, Deborah Reynolds, Jasleen Sidhu, et al.
European Heart Journal|June 2, 2021
What can heart failure trialists learn from oncology trialists?Faiez Zannad, Gad Cotter, Angeles Alonso Garcia, et al.
Journal of Cardiac Failure|April 19, 2023
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre-Cardiogenic ShockMarco Metra, Ovidiu Chioncel, Beth Davison, et al.
Journal of Cardiac Failure|August 28, 2010
The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP studyStephen S Gottlieb, Michael M Givertz, Marco Metra, et al.
Journal of Cardiac Failure|November 26, 2013
Prognostic significance of ECG abnormalities for mortality risk in acute heart failure: insight from the Sub-Saharan Africa Survey of Heart Failure (THESUS-HF)Anastase Dzudie, Olga Milo, Christopher Edwards, et al.
American Heart Journal|November 18, 2005
Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathyAlex Blatt, Gad Cotter, Marina Leitman, et al.
Pageof 29

Showing results (101-110 of 290) with videos related to

Sort By:
Pageof 29
ESC Heart Failure|November 28, 2020
N-terminal pro BNP and galectin-3 are prognostic biomarkers of acute heart failure in sub-Saharan Africa: lessons from the BAHEF trialMahmoud U Sani, Albertino Damasceno, Beth A Davison, et al.
Cardiology|September 18, 2007
Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension--a multi-center randomized studyEdo Kaluski, Gad Cotter, Marina Leitman, et al.
Journal of Cardiac Failure|February 14, 2025
Acute Heart Failure: Transitioning From Symptom-Based Care to RemissionGad Cotter, Beth A Davison, Douglas L Mann, et al.
Journal of Cardiac Failure|February 4, 2010
Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal functionBeth Davison Weatherley, Gad Cotter, Howard C Dittrich, et al.
Scientific Reports|August 12, 2025
Reducing blood pressure variability-results from a single-arm proof of concept prospective trialEyal Shemesh, Deborah Reynolds, Jasleen Sidhu, et al.
European Heart Journal|June 2, 2021
What can heart failure trialists learn from oncology trialists?Faiez Zannad, Gad Cotter, Angeles Alonso Garcia, et al.
Journal of Cardiac Failure|April 19, 2023
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre-Cardiogenic ShockMarco Metra, Ovidiu Chioncel, Beth Davison, et al.
Journal of Cardiac Failure|August 28, 2010
The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP studyStephen S Gottlieb, Michael M Givertz, Marco Metra, et al.
Journal of Cardiac Failure|November 26, 2013
Prognostic significance of ECG abnormalities for mortality risk in acute heart failure: insight from the Sub-Saharan Africa Survey of Heart Failure (THESUS-HF)Anastase Dzudie, Olga Milo, Christopher Edwards, et al.
American Heart Journal|November 18, 2005
Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathyAlex Blatt, Gad Cotter, Marina Leitman, et al.
Pageof 29